Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Simon R. Johnson"'
Funder: Nottingham Molecular Pathology Node
Funder: NIHR Rare Diseases Translational Research Collaboration
Background: Lymphangioleiomyomatosis (LAM) is a rare multisystem disease almost exclusively affecting women which causes loss of lun
Funder: NIHR Rare Diseases Translational Research Collaboration
Background: Lymphangioleiomyomatosis (LAM) is a rare multisystem disease almost exclusively affecting women which causes loss of lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c57dddbac3e27fe082cd5760992f137
https://www.repository.cam.ac.uk/handle/1810/306638
https://www.repository.cam.ac.uk/handle/1810/306638
Publikováno v:
Medical hypotheses. 141
Lymphangioleiomyomatosis (LAM) is a cystic lung disease mainly affecting women, in which degradation of the lung parenchyma is associated with a cell of unknown provenance, known as a LAM cell. LAM cells carry TSC2 mutations and can be identified in
Autor:
Kevin K. Brown, Yoshikazu Inoue, Karen Smith, Kevin C. Wilson, Angelo M. Taveira-Da Silva, Steven A. Sahn, Gregory P. Downey, Simon R. Johnson, Vincent Cottin, Kuniaki Seyama, Nishant Gupta, MeiLan K. Han, Jeffrey T. Chapman, Eugene J. Sullivan, Jan Brozek, Lisa R. Young, Elizabeth P. Henske, Jeanine D'Armiento, Joel Moss, Geraldine R. Finlay, John J. Bissler, Cristopher A. Meyer, Francis X. McCormack, Robert M. Kotloff, Wendy K. Steagall, Thomas V. Colby, Jay H. Ryu, Charlie Strange, Jean F. Cordier, Kathryn A. Wikenheiser-Brokamp, Brent W. Kinder, Connie G. Glasgow
Background: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily affects women. The purpose of these guidelines is to provide recommendations for the diagnosis and treatment of LAM.Methods: Systematic reviews were performed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3747eb67c592ce58b0178884bf638418
https://europepmc.org/articles/PMC5803656/
https://europepmc.org/articles/PMC5803656/